Related by context. Frequent words. (Click for all words.) 63 Daclizumab 63 forodesine 62 elotuzumab 61 teriflunomide 61 phase Ib 61 Factor VIIa 60 enzastaurin 60 recurrent glioblastoma 60 INCB# [001] 60 Phase Ib II 59 placebo controlled clinical 59 bicifadine 59 Laquinimod 59 phase IIa 59 ixabepilone 59 atacicept 59 Initiate Phase 59 Phase IIb trials 59 pertuzumab 59 Allovectin 7 R 59 KNS # 58 phase IIb 58 relapsing multiple sclerosis 58 custirsen 58 ocrelizumab 58 refractory chronic lymphocytic 58 BrachySil 58 phase IIa clinical 58 Phase 2b clinical trials 58 tanespimycin 58 bosutinib 58 RRMS patients 58 MKC# 57 Lu AA# 57 Desmoteplase 57 phase 2a 57 Bicifadine 57 phase IIb clinical 57 EndoTAG TM -1 57 bendamustine 57 ATL# [001] 57 HGS ETR1 57 Pivotal Phase III 57 GLPG# 57 Alemtuzumab 56 BZL# 56 Natalizumab 56 PEG SN# 56 dacetuzumab 56 Panzem R 56 CCX# 56 IMC #B 56 axitinib 56 Phase Ib clinical 56 nab paclitaxel 56 deforolimus 56 Asentar 56 proteasome inhibitor 56 Ostarine 56 sunitinib malate 56 KRN# 56 Nuvion 56 HuMax CD# 55 pharmacodynamic effects 55 tezampanel 55 Tavocept 55 Synavive 55 Phenoptin 55 CORT # 55 SAR# [004] 55 registrational trial 55 Pivotal Phase 55 CR# vcMMAE 55 IIa trial 55 Amrubicin 55 Mipomersen 55 Diamyd ® 55 goserelin 55 fenretinide 55 metastatic hormone refractory 55 AeroLEF TM 55 senicapoc 55 darapladib 55 IMC A# 55 R sorafenib tablets 55 confirmatory Phase III 55 Telcyta 54 liposomal formulation 54 interferon beta 1b 54 eniluracil 54 Imprime PGG 54 ganetespib 54 otelixizumab 54 Urocidin 54 Azedra 54 double blinded placebo 54 hematologic toxicity 54 drug conjugate 54 ELND# 54 multicenter Phase 54 EZN